CCG-203971
CAS: 1443437-74-8
Ref. TM-T4306
| 5mg | 36.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 94.00 € | ||
| 50mg | 164.00 € | ||
| 100mg | 245.00 € | ||
| 500mg | 597.00 € | ||
| 1ml*10 (DMSO) | 40.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Product Information
Name:
CCG-203971
Synonyms:
- CCG203971
CAS:
Description:
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
408.88
Formula:
C23H21ClN2O3
Purity:
99.35%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T4306 CCG-203971
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
